Patents by Inventor Henry Rendon Barragan

Henry Rendon Barragan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • UMBILICAL CORD BIOMATERIAL FOR MEDICAL USE
    Publication number: 20120114712
    Abstract: The present invention provides a biomaterial comprising a mammalian umbilical cord membrane. The biomaterial can additionally comprise Wharton's jelly and/or one or more umbilical cord vessels. The biomaterial is preferably dry, and can be flat, tubular, or shaped to fit a particular body structure. The invention further provides laminates comprising at least one layer of an umbilical cord membrane biomaterial. The invention further provides methods of making the biomaterial, and laminates comprising the biomaterial, and methods of using the biomaterial.
    Type: Application
    Filed: December 21, 2011
    Publication date: May 10, 2012
    Inventors: Qing Liu, Henry Rendon Barragan, George Matcham
  • Umbilical cord biomaterial for medical use
    Patent number: 8105634
    Abstract: The present invention provides a biomaterial comprising a mammalian umbilical cord membrane. The biomaterial can additionally comprise Wharton's jelly and/or one or more umbilical cord vessels. The biomaterial is preferably dry, and can be flat, tubular, or shaped to fit a particular body structure. The invention further provides laminates comprising at least one layer of an umbilical cord membrane biomaterial. The invention further provides methods of making the biomaterial, and laminates comprising the biomaterial, and methods of using the biomaterial.
    Type: Grant
    Filed: August 15, 2007
    Date of Patent: January 31, 2012
    Assignee: Anthrogenesis Corporation
    Inventors: Qing Liu, Henry Rendon Barragan, George Matcham
  • ANGIOGENIC CELLS FROM HUMAN PLACENTAL PERFUSATE
    Publication number: 20090104164
    Abstract: Provided herein are the production of vasculogenic or angiogenic cells from placental perfusate. Also provided are methods of treating an individual having a cardiac or vascular insufficiency, disease, disorder or condition comprising administering to said individual placental perfusate, placental perfusate cells, or combinations of placental perfusate or perfusate cells with placental or non-placental hematopoietic stem cells or adherent placental stem cells.
    Type: Application
    Filed: September 26, 2008
    Publication date: April 23, 2009
    Applicant: Celgene Cellular Therapeutics
    Inventors: Xiaokui Zhang, Mohammad A. Heidaran, Vanessa R. Voskinarian-Berse, Lin Kang, Henry Rendon Barragan
  • Umbilical cord biomaterial for medical use
    Publication number: 20080069895
    Abstract: The present invention provides a biomaterial comprising a mammalian umbilical cord membrane. The biomaterial can additionally comprise Wharton's jelly and/or one or more umbilical cord vessels. The biomaterial is preferably dry, and can be flat, tubular, or shaped to fit a particular body structure. The invention further provides laminates comprising at least one layer of an umbilical cord membrane biomaterial. The invention further provides methods of making the biomaterial, and laminates comprising the biomaterial, and methods of using the biomaterial.
    Type: Application
    Filed: August 15, 2007
    Publication date: March 20, 2008
    Inventors: Qing Liu, Henry Rendon Barragan, George Matcham